Eli Lilly & Co. (LLY) Tops Q1 EPS by $1.58, Beats on Revenue; Offers Strong Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,433.08 +1.68%
Financial Fact:
Acquired in-process research and development: 0
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Acquired in-process research and development: 0
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $8.55, $1.58 better than the analyst estimate of $6.97. Revenue for the quarter came in at $19.8 billion versus the consensus estimate of $17.6 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2026 EPS of $35.50-$37.00, versus the consensus of $34.53. Eli Lilly & Co. sees FY2026 revenue of $82-85 billion, versus the consensus of $81.67 billion.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Airbnb (ABNB) call put ratio 1 call to 1.3 puts into quarter results
- Berkshire Hathaway hits 52-week high on election rally
- Reservoir Media, Inc. (RSVR) Tops Q2 EPS by 2c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
